ApprovalTrail

Approval · Notice of Compliance 14717 · 2013

VEREGEN: Notice of Compliance 14717

Issued September 5, 2013

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
14717
Date
September 5, 2013
Company
Triton Pharma Inc.Concord, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Topical treatment of genital warts

Products in this notice

BrandDINStatus today
VEREGEN02411849Marketed

Medicinal ingredients